Development
E
Cardlytics, Inc. CDLX
$1.79 $0.116.55% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2023 09/30/2023 06/30/2023 03/31/2023 12/31/2022
Net Income -320.75% -1.95% -272.75% 103.60% -6,136.05%
Total Depreciation and Amortization 5.32% -19.31% 4.61% -11.40% -25.04%
Total Amortization of Deferred Charges -0.24% 0.73% 1.23% 0.99% 0.25%
Total Other Non-Cash Items 372.09% -1.25% 178.31% -107.58% 1,116.59%
Change in Net Operating Assets -49.44% -210.96% 74.09% 59.41% -422.21%
Cash from Operations 145.73% -79.24% 157.14% 23.18% 9.24%
Capital Expenditure -437.25% -383.33% 105.00% -344.44% 59.70%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -10.60% -11.93% -13.23% 20.51% 1.00%
Cash from Investing 56.55% -14.52% 1.96% 11.13% 4.57%
Total Debt Issued -- -- -100.00% -- --
Total Debt Repaid 0.00% -42.86% -75.00% 63.64% -266.67%
Issuance of Common Stock -100.00% 300.00% -- -- --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 546.15% 99.97% -333,766.67% 90.00% -2,042.86%
Cash from Financing 128.57% 100.04% -267.03% 16,849.16% -2,883.33%
Foreign Exchange rate Adjustments 201.35% -25.42% -133.52% 203.53% 78.40%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 184.29% 95.75% -372.58% 204.14% 10.40%